|
1
|
Sehgal NV, Verma P and Chatterjee K: Type
1 neurofibromatosis (von Recklinghausen disease). Cutis. 96:e23–26.
2015.PubMed/NCBI
|
|
2
|
Leroy K, Dumas V, Martin-Garcia N, Falzone
MC, Voisin MC, Wechsler J, Revuz J, Creange A, Levy E, Lantieri L,
et al: Malignant peripheral nerve sheath tumors associated with
neurofibromatosis type 1: A clinicopathologic and molecular study
of 17 patients. Arch Dermatol. 137:908–913. 2001.PubMed/NCBI
|
|
3
|
Feldman DS, Jordan C and Fonseca L:
Orthopaedic manifestations of neurofibromatosis type 1. J Am Acad
Orthop Surg. 18:346–357. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hirbe AC and Gutman DH: Neurofibromatosis
type 1: A multidisciplinary approach to care. Lancet Neurol.
13:834–843. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ferner RE, Huson SM, Thomas N, Moss C,
Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C
and Kirby A: Guidelines for the diagnosis and management of
individuals with neurofibromatosis 1. J Med Genet. 44:81–88.
2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Boyd KP, Korf BR and Theos A:
Neurofibromatosis type 1. J Am Acad Dermatol. 61:1–14.
2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Guler M, Aydin T and Poyraz E:
Neurofibromatosis type 1 with invasive spinal cord compression
(case report). Afr J Pharm Pharmacol. 7:1615–1618. 2013.
|
|
8
|
Friedman JM: Epidemiology of
neurofibromatosis type 1. Am J Med Genet. 89:1–6. 1999.PubMed/NCBI
|
|
9
|
Lammert M, Friedman JM, Kluwe VF and
Mautner VF: Prevalence of neurofibromatosis 1 in German children at
elementary school enrollment. Arch Dermatol. 141:71–74.
2005.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Huson SM, Compston DA, Clark P and Harper
PS: A genetic study of von Recklinghausen neurofibromatosis in
south east Wales. Prevalence, fitness, mutaton rate and effect of
parental transmision on severity. J Med Genet. 26:704–711.
1989.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gutmann DH, Ferner RE, Listernick RH, Korf
BR, Wolters PL and Johnson KJ: Neurofibromatosis type 1. Nat Rev
Dis Primers. 3(17004)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nica SC, Mihailescu G, Nica SM, Baetu C,
Clatici VG and Buruga I: Neurofibromatosis-one disease for a
multidisciplinary team. RoJCED. 3:38–49. 2016.
|
|
13
|
Viskochil D, Buchberg AM, Xu G, Cawthon
RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG and
Jenkins NA: Deletions and a translocation interrupt a cloned gene
at the neurofibromatosis type 1 locus. Cell. 62:187–192.
1990.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li Y, O'Connell P, Breidenbach HH, Cawthon
R, Stevens J, Xu G, Neil S, Robertson M, White R and Viskochil D:
Genomic organization of the neurofibromatosis 1 gene (Nf1).
Genomics. 25:9–18. 1995.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Daston MM, Scrable H, Nordlund M, Sturbaum
AK, Nissen LM and Ratner N: The protein product of the
neurofibromatosis type 1 gene is expressed at highest abundance in
neurons, Schwann cells and oligodendrocytes. Neuron. 8:415–428.
1992.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gutmann DH, Parada LF, Silva AJ and Ratner
N: Neurofibromatosis type 1: Modeling CNS dysfunction. J Neurosci.
32:14087–14093. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Peltonen S: Neurofibromatosis type 1:
Dermatologists should take an active role. Forum for Nord Derm Ven.
13:74–77. 2008.
|
|
18
|
Antônio JR, Goloni-Bertollo EM and Trídico
LA: Neurofibromatosis: Chronological history and current issues. An
Bras Dermatol. 88:329–343. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Stocker KM, Baizer L, Coston T, Sherman L
and Ciment G: Regulated expression of neurofibromin in migrating
neural crest cells of avian embryos. J Neurobiol. 27:535–552.
1995.PubMed/NCBI View Article : Google Scholar
|
|
20
|
National Institutes of Health Consensus
Development Conference Statement: Neurofibromatosis. Bethesda, Md.,
USA July 13-15, 1987. Neurofibromatosis. 1:172–178. 1988.PubMed/NCBI
|
|
21
|
Tonsgard JH: Clinical manifestations and
management of neurofibromatosis type 1. Semin Pediatr Neurol.
13:2–7. 2006.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ferner RE: Neurofibromatosis 1. Eur J Hum
Genet. 15:131–138. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Williams VC, Lucas J, Babcock MA, Gutmann
DH, Korf B and Maria BL: Neurofibromatosis type 1 revisited.
Pediatrics. 123:124–133. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kolanczyk M, Mautner V, Kossler N, Nguyen
R, Kuhnisch J, Zemojtel T, Jamsheer A, Wegener E, Thurisch B,
Tinschert S, et al: MIA is a potential biomarker for tumour load in
neurofibromatosis type 1. BMC Med. 9(82)2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tatu AL: Umbilicated blue black lesion on
the lateral thorax. J Cutan Med Surg. 21(252)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Valeyrie-Allanore L, Ortonne N, Lentieri
L, Ferkal S, Wechsler J, Bagot M and Wolkenstein P:
Histopathologically dysplastic neurofibromas in neurofibromatosis
1: Diagnostic criteria, prevalence and clinical signifiance. Br J
Dermatol. 158:1008–1012. 2008.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Montani D, Coulet F, Girerd B, Eyries M,
Bergot E, Mal H, Biondi G, Dromer C, Hugues T, Marquette C, et al:
Pulmonary hypertension in patients with neurofibromatosis type I.
Medicine (Baltimore). 90:201–211. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang J, Wei G, Wang Z and Huang H:
Detection of severe hypertension in a patient with
neurofibromatosis type 1 during anesthesia induction: A case
report. J Med Case Rep. 13(349)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nanda A: Autoimmune diseases associated
with neurofibromatosis type 1. Pediatr Dermatol. 25:392–393.
2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tatu AL and Ionescu MA: Multiple
autoimmune syndrome type III-thyroiditis, vitiligo and alopecia
areata. Acta Endocrinol (Buchar). 13:124–125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tandon S, Singh A, Arora P and Gautam RK:
Neurofibromatosis with vitiligo: An uncommon association rather
than coexistence? An Bras Dermatol. 94:624–626. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Miraglia E, Calvieri S and Giustini S:
Neurofibromatosis type 1 and lichen sclerosus: An uncommon
association. G Ital Dermatol Venereol. 152:83–84. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mihăilă B, Dinică RM, Tatu AL and Buzia
OD: New insights in vitiligo treatments using bioactive compounds
from Piper nigrum. Exp Ther Med. 17:1039–1044.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tatu AL and Nwabudike LC: The treatment
options of male genital lichen sclerosus et atrophicus: Treatments
of genital lichen sclerosus. In: Proceedings of the 14th National
Congress of Urogynecology and the National Conference of the
Romanian Association for the Study of Pain, pp262-264, 2017.
|
|
35
|
Korf BR: Diagnostic outcome in children
with cafe au lait spots. Pediatrics. 90:924–927. 1992.PubMed/NCBI
|
|
36
|
Stevenson DA, Moyer-Mileur LJ, Murray M,
Slater H, Sheng X, Carey JC, Dube B and Viskochil DH: Bone mineral
density in children and adolescents with neurofibromatosis type 1.
J Pediatr. 150:83–88. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Friedman JM and Birch PH: Type I
neurofibromatosis: A descriptive analysis of the disorder in 1728
patients. Am J Med Genet. 70:138–143. 1997.
|
|
38
|
Gilbert A and Brockman R: Congenital
pseudarthrosis of the tibia: Long-term followup of 29 cases treated
by microvascularbone transfer. Clin Orthop Relat Res. 314:37–44.
1995.PubMed/NCBI
|
|
39
|
Sulaiman AR, Nordin S, Faisham WI, Zulmi W
and Halim AS: Residual nonunion following vascularized fibular
graft treatment for congenital pseudarthosis of the tibia: A report
of two cases. J Orthop Surg (Hong Kong). 14:64–66. 2006.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Stevenson DA, Birch PH, Friedman JM,
Viskochil DH, Balestrazzi P, Boni S, Buske A, Korf BR, Niimura M,
Pivnick EK, et al: Descriptive analysis of tibial pseudarthrosis in
patients with neurofibromatosis 1. Am J Med Genet. 84:413–419.
1999.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kong LD, Cheng HX and Nie T: Treat the
congenital pseudarthrosis of the tibia with Ilizarov technology.
Case report. Medicine (Baltimore). 97(e13384)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sakamoto A, Yoshida T, Yamamoto H, Oda Y,
Tsuneyoshi M and Iwamoto Y: Congenital pseudarthrosis of the tibia:
Analysis of the histology and the NF1 gene. J Orthop Sci.
12:361–365. 2007.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Tuncay IC, Johnston CE II and Birch JG:
Spontaneous resolution of congenital anterolateral bowing of the
tibia. J Pediatr Orthop. 14:599–602. 1994.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Crawford AH and Schorry EK:
Neurofibromatosis in children: The role of the orthopaedist. J Am
Acad Orthop Surg. 7:217–230. 1999.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Traub JA, O'Connor W and Masso PD:
Congenital pseudarthrosis of the tibia: A retrospective review. J
Pediatr Orthop. 19:735–738. 1999.PubMed/NCBI
|
|
46
|
Karol LA, Haideri NF, Halliday SE,
Smitherman TB and Johnston CE II: Gait analysis and muscle strength
in children with congenital pseudarthrosis of the tibia: The effect
of treatment. J Pediatr Orthop. 18:381–386. 1998.PubMed/NCBI
|
|
47
|
Vanderstappen J, Lammens J, Berger P and
Laumen A: Ilizarov bone transplant as a treatment of congenital
pseudarthrosis of the tibia: A long-term follow-up study. J Child
Orthop. 9:319–324. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ippolito E, Corsi A, Grill F, Wientroub S
and Bianco P: Pathology of bone lesions associated with congenital
pseudarthrosis of the leg. J Pediatr Orthop B. 9:3–10.
2000.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Hefti F, Bollini C, Dungl P, Fixsen J,
Grill F, Ippolito E, Romanus B, Tudisco C and Wientroub S:
Congenital pseudarthrosis of the tibia: History, etiology,
classification and epideiologic data. J Pediatr Orthop B. 9:11–15.
2000.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Lehman WB, Atar D, Feldman DS, Gordon JC
and Grant AD: Congenital pseudarthrosis of the tibia. J Pediatr
Orthop B. 9:103–107. 2000.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Tudisco C, Bollini C, Dungel P, Fixen J,
Grill F, Hefti F, Romanus B and Wientroub S: Functional results at
the end of skeletal growth in 30 patients affected by congenital
pseudarthrosis of the tibia. J Pediatr Orthop B. 9:94–102.
2000.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Grill F, Bollini C, Dungl P, Fixsen J,
Hefti F, Ippolito E, Romanus B, Tudisco C and Wientroub S:
Treatment approaches for congenital psedarthrosis of tibia: Results
of the EPOS multicenter study. European Paediatric Orthopaedic
Society (EPOS). J Pediatr Orthop B. 9:75–89. 2000.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Elefteriou F, Kolnczyk M, Schindeler A,
Viskochil DH, Hock JM, Schorry EK, Crawford AH, Friedman JM, Little
D, Peltonen J, et al: Skeletal abnormalities in neurofibromatosis
type 1: Approaches to therapeutic options. Am J Med Genet A. 149A.
2327–2338. 2009.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Dobbs MB, Rich MM, Gordon JE, Szymanski DA
and Schoenecker PL: Use of an intramedullary rod for treatment of
congenital pseudarthrosis of the tibia: A long-term follow-up
study. J Bone Joint Surg Am. 86:1186–1197. 2004.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Boero S, Catagni M, Donzelli O, Facchini R
and Frediani PV: Congenital pseudarthrosis of the tibia associated
with neurofibromatosis 1: Treatment with Ilizarov's device. J
Pediatr Orthop. 17:675–684. 1997.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Velan CJ, Katz K and Hendel D: Failed
treatment of congenital pseudarthrosis of the tibia-a case of
Ilizarov transportation of proximal tibia with artrodesis to talus.
Acta Orthop Scand. 69:433–434. 1998.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Ramachandran M, Tsirikos AI, Lee J and
Saifuddin A: Whole-spine magnetic resonance imaging in patients
with neurofibromatosis type 1 and spinal deformity. J Spinal Disord
Tech. 17:483–491. 2004.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Singh K, Samartzis D and An HS:
Neurofibromatosis type 1 with severe dystrophic kyphoscoliosis and
its operative management via a simultaneous anterior-posterior
approach: A case report and review of the literature. Spine J.
5:461–466. 2005.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Li M, Fang X, Li Y, Ni J, Gu S and Zhu X:
Succesful use of posterior instrumented spinal fusion alone for
scoliosis in 19 patients with neurofibromatosis type-1 followed up
for at least 25 months. Arch Orthop Trauma Surg. 129:915–921.
2009.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ardeleanu V, Chicoş SC, Tutunaru D and
Georgescu C: Multiple benign symmetric lipomatosis-a differential
diagnosis of obesity. Chirurgia (Bucur). 108:580–583.
2013.PubMed/NCBI
|
|
61
|
Ardeleanu V, Toma A, Pafili K, Papanas N,
Motofei I, Diaconu CC, Rizzo M and Stoian AP: Current
pharmacological treatment of painful diabetic neuropathy: A
narrative review. Medicina (Kaunas). 56(25)2020.PubMed/NCBI View Article : Google Scholar
|
